Sale to Envision Pharma Group

Sale to Envision Pharma Group


Baird served as the exclusive financial advisor to Two Labs on this transaction


TL Life Science Solutions, LLC, dba Two Labs (“Two Labs” or the “Company”), a portfolio company of Excellere Partners, LLC (“Excellere”), was acquired by Envision Pharma Group (“Envision”), which recently received an increased investment from its majority owner, GHO Capital Partners LLP (“GHO”). Terms of the transaction were not disclosed.

Two Labs is a leading pharmaceutical services company that partners with pharma/biotech companies, providing integrated and customized commercial solutions. The Company helps chart the path from clinical to commercial for a new product launch and provides strategies for continued market viability for drugs on the market. Since its inception in 2003, Two Labs has led more than 215 new product launches and more than 300 in-market projects from pre-launch to loss of exclusivity. Two Labs is headquartered in Powell, Ohio.

Excellere is a United States-based private equity firm focused on partnering with entrepreneurs and management teams in emerging growth companies. Excellere focuses on the unique needs of emerging private companies with aspirations to build industry leadership and enduring value. Excellere is headquartered in Denver, Colorado.

Founded in 2001, Envision is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility. Envision provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies. Envision is headquartered in Horsham, the United Kingdom.

GHO is a leading specialist healthcare investment advisor that applies global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market-leading businesses of strategic global value. GHO’s proven investment track record reflects the unrivaled depth of its industry expertise and network. GHO partners with strong management teams to unlock value in a global system that demands the delivery of better, faster, more accessible healthcare. GHO is headquartered in London, the United Kingdom.
Sale to Envision Pharma Group
November 2020
Two Labs
Target Location
North America
Acquiror Location